Verdict76/ 100
Grade C · #40Breeze Meds
A LegitScript-certified nationwide programme that charges nothing until a provider approves you — but hides its pricing until you are inside the intake.
Visit Breeze MedsHead-to-head verdict
Breeze Meds vs ShedRx
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict87/ 100
Grade B+ · #5ShedRx
The widest formulary on this board — injections, drops, lozenges and an oral pill, plus real brand Zepbound — with health coaching bundled in.
Visit ShedRxThe verdict
Winner: ShedRx
ShedRx takes it with a higher Verdict Score — 87/100 to 76/100 (grade B+ vs C). People who want options rather than one route: a needle-free form, a brand pathway, or coaching included instead of sold separately. Breeze Meds still earns its place — people who want an all-in nationwide option and do not mind completing an intake to find out what it actually costs.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
74Real-world results86
74
Real-world results86
70Price honesty86
70
Price honesty86
76Prescriber access83
76
Prescriber access83
72Formulary choice90
72
Formulary choice90
86Cancellation fairness88
86
Cancellation fairness88
76Member support88
76
Member support88
Price, coverage & features
| Metric | Breeze Meds | ShedRx |
|---|---|---|
| Verdict Score | 76/100 | 87/100 |
| Grade | C | B+ |
| Semaglutide | From $199/mo | $199/mo |
| Tirzepatide | From $299/mo first month, $399/mo thereafter | $299/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
Breeze Meds
What we like
- Nothing is charged until a provider approves you, and the consult is free if you go ahead
- One inclusive price covering consult, medication, supplies, shipping and support
- LegitScript certified, available in all 50 states, cancel or change plan at any time
- NAD+ injections offered alongside the GLP-1 line if you want both from one provider
The caveats
- The public site advertises “weight loss injections from $199” without naming a molecule; tirzepatide pricing only appears inside the intake
- Every quoted figure is for the LOWEST dose — the funnel says higher doses may cost more, so these are floors, not titrated-dose prices
- An $80 consultation fee applies if you are approved and then decide not to proceed
- Compounded only, with no brand-name pathway and no oral route
ShedRx
What we like
- Four routes to a GLP-1 — injection, liquid drops, lozenges and an oral daily pill — plus brand Zepbound and Wegovy
- Tirzepatide $299/mo month-to-month falling to $239 on a twelve-month plan; semaglutide $199 falling to $159
- Health coaching included with membership rather than upsold
- Publishes a 120-day weight-loss guarantee, which almost nothing else here offers
The caveats
- The advertised "as low as $239" tirzepatide rate requires committing to twelve months — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Also worth a look
People who want an all-in nationwide option and do not mind completing an intake to find out what it actually costs.
Visit Breeze Meds Read the full Breeze Meds review →Our pick — visit
People who want options rather than one route: a needle-free form, a brand pathway, or coaching included instead of sold separately.
Visit ShedRx Read the full ShedRx review →Keep comparing
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.